Psoriasis During Pregnancy: Expert Guide For Safe Treatment
Safe strategies for managing psoriasis symptoms before, during, and after pregnancy to protect maternal and fetal health.
Navigating psoriasis management during pregnancy requires balancing symptom control with fetal safety. Many women experience fluctuations in their condition due to hormonal shifts, making informed treatment choices essential.
Understanding Psoriasis Changes in Expectant Mothers
Psoriasis symptoms can improve, stabilize, or worsen during pregnancy. Studies show about half of patients see improvement, particularly from weeks 10 to 20, possibly linked to elevated estrogen or progesterone levels that modulate immune responses. Postpartum, flares are common, affecting up to 65% of women by six weeks after delivery, necessitating proactive planning.
Hormonal influences play a key role: higher estrogen may suppress T-cell activity, while progesterone could directly limit skin cell overgrowth. However, severe uncontrolled inflammation risks pregnancy complications like preterm birth or preeclampsia.
Pre-Conception Planning for Optimal Control
Ideal management starts before pregnancy. Achieving remission with safe therapies minimizes flare risks. Women on systemic drugs like methotrexate or biologics should discontinue them months in advance, as advised by dermatologists, to clear the body safely.
- Consult specialists early to switch to pregnancy-compatible options.
- Optimize topical or light-based regimens for stability.
- Discuss family planning with healthcare providers to align treatments.
Safe Topical Treatments for Mild Cases
For mild psoriasis, non-medicated options form the foundation. Emollients like petroleum jelly or mineral oil hydrate skin, prevent irritation, and reduce flare triggers without systemic absorption risks.
Low- to mid-potency topical corticosteroids are first-line for active plaques. These do not raise birth defect risks or preterm labor when used judiciously, though potent versions should be limited to short durations to avoid stretch marks.
| Treatment Type | Safety Level | Usage Notes |
|---|---|---|
| Moisturizers/Emollients | High | Apply freely; no known risks. |
| Low-Mid Potency Steroids | High | First choice; limit potent to <300g total. |
| Vitamin D Analogues (e.g., Calcipotriene) | Moderate | Use low doses; consult dermatologist. |
Avoid salicylic acid, retinoids, coal tar, and calcineurin inhibitors due to potential absorption and unproven safety.
Light Therapy Options for Moderate Symptoms
Narrowband UVB or broadband UVB phototherapy offers effective control for broader involvement. These are deemed safe throughout pregnancy, with no reported fetal harm.
Treatments require clinic visits 2-3 times weekly, which may challenge mobility in late pregnancy. No breastfeeding contraindications exist, though logistics with newborns can be tricky.
Systemic Therapies: When and What to Consider
Avoid most oral systemics, especially in the first trimester, due to teratogenic risks. Cyclosporine (CsA) stands out as relatively safe based on transplant patient data, usable as rescue for severe refractory cases after risk-benefit assessment.
Biologics like anti-TNF agents (etanercept, adalimumab, infliximab) have limited data but appear viable for severe disease if started early and stopped before third trimester to limit placental transfer. Monoclonal antibodies cross the placenta late-term, with prolonged infant half-life.
- CsA: Preferred systemic; no contraception needed pre-pregnancy.
- Biologics: Case-by-case; monitor newborn immunity.
- Methotrexate/Acitretin: Strictly contraindicated.
Breastfeeding Considerations and Adjustments
Topicals remain primary: emollients, low-potency steroids, apply post-feed and rinse before next. UVB phototherapy continues safely.
Systemic avoidance is standard due to insufficient long-term data; pump-and-dump may apply for short-term needs. Biologics like certolizumab pegol show lower milk transfer.
Postpartum Flare Prevention and Management
Post-delivery worsening is frequent, driven by hormonal drops and sleep disruption. Restart pre-pregnancy regimens promptly if cleared for breastfeeding.
Monitor for psoriatic arthritis overlap, which may elevate preterm risks. Multidisciplinary care with obstetricians, dermatologists, and rheumatologists optimizes outcomes.
Potential Pregnancy Complications Linked to Psoriasis
Active psoriasis may heighten preterm delivery or preeclampsia odds, underscoring treatment importance. No direct fetal malformations from psoriasis itself, but untreated inflammation warrants intervention.
Frequently Asked Questions
Can psoriasis harm my baby?
No direct harm, but severe cases link to maternal risks like preterm birth.
Is UVB phototherapy safe in pregnancy?
Yes, narrowband and broadband types show no fetal risks.
What topicals to avoid while pregnant?
Salicylic acid, retinoids, coal tar, high-potency steroids long-term.
Can I breastfeed on biologics?
Limited data; prefer topicals, consult provider.
How to prepare psoriasis for pregnancy?
Achieve control pre-conception, switch safe therapies.
Lifestyle Tips for Symptom Management
- Maintain gentle skincare routines to avoid triggers.
- Stay hydrated and use lukewarm baths with oats.
- Manage stress via prenatal yoga or meditation.
- Avoid skin injury, which can worsen plaques.
- Track symptoms to predict patterns.
Collaborate with healthcare teams for personalized plans. Regular check-ins ensure adjustments as pregnancy progresses.
References
- Can a woman treat psoriasis while pregnant or breastfeeding? — American Academy of Dermatology (AAD). 2023. https://www.aad.org/public/diseases/psoriasis/treatment/stage/pregnant
- Psoriasis in pregnancy: challenges and solutions — PMC (NCBI). 2017-10-26. https://pmc.ncbi.nlm.nih.gov/articles/PMC5683115/
- Which Psoriasis Treatments Are Safe During Pregnancy? — American Journal of Managed Care (AJMC). 2023. https://www.ajmc.com/view/which-psoriasis-treatments-are-safe-during-pregnancy
- Treatment and Pregnancy — National Psoriasis Foundation. 2023. https://www.psoriasis.org/treatment-and-pregnancy/
- Management of psoriasis in pregnancy — PMC (NIH). 2007. https://pmc.ncbi.nlm.nih.gov/articles/PMC1889937/
- Psoriasis in pregnancy and during breastfeeding — European Academy of Dermatology and Venereology (EADV). 2023-10. https://eadv.org/wp-content/uploads/2023/10/PREGNANCY-Psoriasis-in-pregnancy-and-during-breastfeeding.pdf
- Psoriasis and Psoriatic Arthritis — MotherToBaby. 2023. https://mothertobaby.org/fact-sheets/psoriasis-and-pregnancy/
Similar Articles
Read full bio of Sneha Tete
